Viridian Therapeutics, Inc. VRDN Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Viridian Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Viridian Therapeutics, Inc.'s compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Viridian Therapeutics, Inc.'s compensation and benefits?
- Viridian Therapeutics, Inc. (VRDN) reported compensation and benefits of $8.36M in Q1 2026.
- How has Viridian Therapeutics, Inc.'s compensation and benefits changed year-over-year?
- Viridian Therapeutics, Inc.'s compensation and benefits increased by 64.1% year-over-year, from $5.1M to $8.36M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s compensation and benefits?
- Over 5 years (2020 to 2025), Viridian Therapeutics, Inc.'s compensation and benefits has grown at a 58.5% compound annual growth rate (CAGR), from $1.96M to $19.66M.